https://economictimes.indiatimes.com/markets/ipos/fpos/concord-biotech-to-list-on-friday-heres-what-gmp-suggests/articleshow/102799875.cms
0
0
8/17/23 at 9:29am
Organization
The Times of India
Author
Akash Podishetti
45 words
0
Comments
Analysts are of the opinion that a market premium of over 15% on the issue price is justified based on the company's business model, which comprises many niche biopharma products
You are the first to view
Create an account
or login to join the discussion